The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for HCP Investments
INDSWFTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.4 pts less than Nifty Microcap 250 and 1.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
HCP Investments, a Mauritius-based non-promoter shareholder, has sold 6,503,423 equity shares (7.5% of total paid-up capital) of Ind-Swift Laboratories Limited through open market transactions. The sale was executed between 13 April and 16 April 2026. Prior to the sale, HCP held 7,500,000 shares (8.649%). After the sale, their holding reduced significantly to 996,577 shares (1.149%). The acquirer is explicitly stated as NOT belonging to the Promoter/Promoter group.
A substantial reduction in a non-promoter shareholder's stake from 8.65% to 1.15%, indicating exit or significant reduction in holding by this investor. This does not directly impact promoter holding but may signal reduced institutional confidence or profit-taking.